Annotation Detail for LMO7


Gene Symbol: | LMO7 ( FBX20,FBXO20,KIAA0858,LOMP ) |
---|---|
Gene Full Name: | LIM domain 7 |
Band: | 13q22.2 |
Quick Links | Entrez ID:4008; OMIM: 604362; Uniprot ID:LMO7_HUMAN; ENSEMBL ID: ENSG00000136153; HGNC ID: 6646 |
Relate to Another Database: | SFARIGene; denovo-db |
Chemical ID | Chemical Name | Interaction | Interaction Action | Publication |
---|---|---|---|---|
C548651 | 2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester | 2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in increased expression of LMO7 mRNA | increases expression | 19933214 |
C014211 | 2,3,7,8-tetrachlorodibenzofuran | 2,3,7,8-tetrachlorodibenzofuran affects the expression of LMO7 mRNA | affects expression | 18343893 |
C016403 | 2,4-dinitrotoluene | 2,4-dinitrotoluene affects the expression of LMO7 mRNA | affects expression | 21346803 |
C023514 | 2,6-dinitrotoluene | 2,6-dinitrotoluene results in decreased expression of LMO7 mRNA | decreases expression | 20406850 |
C023514 | 2,6-dinitrotoluene | 2,6-dinitrotoluene affects the expression of LMO7 mRNA | affects expression | 21346803 |
C009505 | 4,4'-diaminodiphenylmethane | 4,4'-diaminodiphenylmethane affects the expression of LMO7 mRNA | affects expression | 18648102 |
D019324 | beta-Naphthoflavone | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of LMO7 mRNA | affects cotreatment|increases expression | 18164116 |
D015123 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of LMO7 mRNA | decreases expression | 20018196 19150397 |
D003513 | Cycloheximide | Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of LMO7 mRNA] | decreases reaction|increases expression | 11007951 |
D016572 | Cyclosporine | Cyclosporine results in decreased expression of LMO7 mRNA | decreases expression | 20106945 |
D004052 | Diethylnitrosamine | Diethylnitrosamine results in increased expression of LMO7 mRNA | increases expression | 17854601 |
D004052 | Diethylnitrosamine | RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of LMO7 mRNA] | decreases reaction|increases expression | 17854601 |
D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of LMO7 mRNA | affects cotreatment|increases expression | 18164116 |
D005480 | Flurbiprofen | Flurbiprofen results in increased expression of LMO7 mRNA | increases expression | 16949054 |
D007657 | Ketone Bodies | Ketone Bodies results in decreased expression of LMO7 mRNA | decreases expression | 16807920 |
D010634 | Phenobarbital | NR1I3 protein affects the reaction [Phenobarbital results in increased expression of LMO7 mRNA] | affects reaction|increases expression | 19482888 |
D010634 | Phenobarbital | Phenobarbital results in increased expression of LMO7 mRNA | increases expression | 19482888 |
C079198 | S 1 (combination) | LMO7 protein results in increased susceptibility to S 1 (combination) | increases response to substance | 16734730 |
D013749 | Tetrachlorodibenzodioxin | Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of LMO7 mRNA] | decreases reaction|increases expression | 11007951 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of LMO7 mRNA | increases expression | 11007951 20106945 11489354 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of LMO7 mRNA | affects expression | 18343893 |
D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of LMO7 mRNA | affects binding|increases expression | 16214954 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of LMO7 mRNA | increases expression | 18796159 19933214 |
D013755 | Tetradecanoylphorbol Acetate | [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of LMO7 mRNA | affects cotreatment|affects expression | 16979875 |
C047426 | venlafaxine | venlafaxine results in decreased expression of LMO7 mRNA | decreases expression | 16341940 |
C025643 | vinclozolin | vinclozolin affects the expression of LMO7 mRNA | affects expression | 19015723 |
D015032 | Zinc | [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of LMO7 mRNA | affects cotreatment|affects expression | 16979875 |
Disease ID | Disease Name | Direct Evidence | Inference Chemical Name | Inference Score | Publication |
---|---|---|---|---|---|
MESH:D000014 | Abnormalities, Drug-Induced | Phenobarbital | 8.09 | 6195326 | |
MESH:D000014 | Abnormalities, Drug-Induced | Tetrachlorodibenzodioxin | 8.09 | 15322242 11752688 14514962 | |
MESH:D000169 | Acrodermatitis | Zinc | 5.34 | 16889938 17190629 17202136 | |
MESH:D000236 | Adenoma | 4,4'-diaminodiphenylmethane | 11.00 | 3712494 | |
MESH:D000236 | Adenoma | beta-Naphthoflavone | 11.00 | 19389873 | |
MESH:D000236 | Adenoma | Diethylnitrosamine | 11.00 | 10737359 6695378 | |
MESH:D018248 | Adenoma, Liver Cell | Diethylnitrosamine | 17.00 | 18056438 17620307 17162532 19052882 19061943 16434500 | |
MESH:D018248 | Adenoma, Liver Cell | Phenobarbital | 17.00 | 17620307 | |
MESH:D018248 | Adenoma, Liver Cell | Tetrachlorodibenzodioxin | 17.00 | 16835633 | |
MESH:D011125 | Adenomatous Polyposis Coli | Flurbiprofen | 5.00 | 10680582 | |
MESH:D000544 | Alzheimer Disease | Zinc | 2.74 | 17119284 16580781 16325427 16410023 | |
MESH:D000740 | Anemia | Tetrachlorodibenzodioxin | 2.89 | 11748828 | |
MESH:D000755 | Anemia, Sickle Cell | Zinc | 4.84 | 16916123 | |
MESH:D001008 | Anxiety Disorders | vinclozolin | 3.58 | 19015723 | |
MESH:D001249 | Asthma | Zinc | 2.93 | 17085522 | |
MESH:D001660 | Biliary Tract Diseases | 4,4'-diaminodiphenylmethane | 4.96 | 11289319 1440618 | |
MESH:D001778 | Blood Coagulation Disorders | Tetrachlorodibenzodioxin | 2.98 | 12125929 | |
MESH:D001836 | Body Weight Changes | Tetrachlorodibenzodioxin | 3.73 | 15340226 | |
MESH:D001848 | Bone Diseases, Developmental | Tetrachlorodibenzodioxin | 2.72 | 15746008 | |
MESH:D001930 | Brain Injuries | Zinc | 4.63 | 17109824 | |
MESH:D001943 | Breast Neoplasms | Diethylnitrosamine | 1.98 | 17474063 | |
MESH:D001943 | Breast Neoplasms | Tetrachlorodibenzodioxin | 1.98 | 20435547 | |
MESH:D002277 | Carcinoma | Tetrachlorodibenzodioxin | 2.74 | 16835633 | |
MESH:D006528 | Carcinoma, Hepatocellular | 2,4-dinitrotoluene | 8.76 | 16705839 | |
MESH:D006528 | Carcinoma, Hepatocellular | 2,6-dinitrotoluene | 8.76 | 16705839 | |
MESH:D006528 | Carcinoma, Hepatocellular | 4,4'-diaminodiphenylmethane | 8.76 | 7296757 3581430 | |
MESH:D006528 | Carcinoma, Hepatocellular | Diethylnitrosamine | 8.76 | 19919837 3581430 17978847 20007298 20727157 20524982 18978308 19107877 20214788 19383236 10672840 18494052 19539802 17428255 16830150 17761372 16288022 20084675 18788625 20432363 19171122 18056438 19052882 18971187 18506893 16681979 3084413 20935162 20514400 18691550 16935385 18665156 16569478 21159647 16540662 10737359 19208518 19418558 16502159 19519916 17173139 16779866 17138121 19335982 17055752 11831363 18393292 18785209 16328049 19394651 18210153 16807293 16878318 19822196 16698587 17162532 19701751 20101231 20512989 | |
MESH:D006528 | Carcinoma, Hepatocellular | Phenobarbital | 8.76 | 20007298 17173139 20935162 6705139 1701930 | |
MESH:D002289 | Carcinoma, Non-Small-Cell Lung | S 1 (combination) | 4.05 | 18347146 18212800 | |
MESH:D002292 | Carcinoma, Renal Cell | 4,4'-diaminodiphenylmethane | 2.64 | 7296757 | |
MESH:D002294 | Carcinoma, Squamous Cell | S 1 (combination) | 7.80 | 15984520 | |
MESH:D002294 | Carcinoma, Squamous Cell | Tetradecanoylphorbol Acetate | 7.80 | 18922899 | |
MESH:D002294 | Carcinoma, Squamous Cell | Zinc | 7.80 | 16543248 | |
MESH:D006332 | Cardiomegaly | Tetrachlorodibenzodioxin | 2.33 | 16120746 18670907 18850075 | |
MESH:D002318 | Cardiovascular Diseases | Zinc | 3.61 | 16936243 | |
MESH:D002471 | Cell Transformation, Neoplastic | 2,6-dinitrotoluene | 20.60 | 6135515 | |
MESH:D002471 | Cell Transformation, Neoplastic | 4,4'-diaminodiphenylmethane | 20.60 | 7505956 | |
MESH:D002471 | Cell Transformation, Neoplastic | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 20.60 | 20889678 | |
MESH:D002471 | Cell Transformation, Neoplastic | Cyclosporine | 20.60 | 12371664 | |
MESH:D002471 | Cell Transformation, Neoplastic | Diethylnitrosamine | 20.60 | 17174075 2727394 21159647 7505956 | |
MESH:D002493 | Central Nervous System Diseases | Phenobarbital | 4.19 | 4080065 | |
MESH:D018281 | Cholangiocarcinoma | Diethylnitrosamine | 9.13 | 19052882 | |
MESH:D018281 | Cholangiocarcinoma | Tetrachlorodibenzodioxin | 9.13 | 16835633 | |
MESH:D002779 | Cholestasis | 4,4'-diaminodiphenylmethane | 7.71 | 19486331 9022650 | |
MESH:D002779 | Cholestasis | Cyclosporine | 7.71 | 19486331 | |
MESH:D002972 | Cleft Palate | Tetrachlorodibenzodioxin | 2.08 | 15340226 15668235 8697196 16354765 12621046 | |
MESH:D000013 | Congenital Abnormalities | Tetrachlorodibenzodioxin | 3.00 | 14669216 17141729 | |
MESH:D019465 | Craniofacial Abnormalities | Tetrachlorodibenzodioxin | 2.65 | 10048152 20055451 15322242 | |
MESH:D019465 | Craniofacial Abnormalities | Zinc | 2.65 | 19302082 | |
MESH:D003456 | Cryptorchidism | vinclozolin | 4.28 | 14966744 | |
MESH:D003490 | Cyanosis | 2,4-dinitrotoluene | 10.68 | 18551238 | |
MESH:D003490 | Cyanosis | 2,6-dinitrotoluene | 10.68 | 18551238 | |
MESH:D003866 | Depressive Disorder | venlafaxine | 4.78 | 20305041 | |
MESH:D017449 | Dermatitis, Allergic Contact | 4,4'-diaminodiphenylmethane | 2.74 | 12868966 11906362 8156756 2524372 11298694 8970840 18759878 14531868 | |
MESH:D003877 | Dermatitis, Contact | 4,4'-diaminodiphenylmethane | 3.43 | 3621924 2952479 | |
MESH:D003920 | Diabetes Mellitus | Zinc | 4.15 | 16479319 | |
MESH:D003924 | Diabetes Mellitus, Type 2 | Diethylnitrosamine | 4.17 | 20387270 | |
MESH:D003924 | Diabetes Mellitus, Type 2 | Tetrachlorodibenzodioxin | 4.17 | 17107852 | |
MESH:D056486 | Drug-Induced Liver Injury | 2,4-dinitrotoluene | 11.80 | 21346803 18551238 | |
MESH:D056486 | Drug-Induced Liver Injury | 2,6-dinitrotoluene | 11.80 | 18551238 21346803 | |
MESH:D056486 | Drug-Induced Liver Injury | 4,4'-diaminodiphenylmethane | 11.80 | 6679447 9328219 16192314 18692083 1440618 18289764 9653073 18648102 11289319 8291058 7440962 6482804 9022650 | |
MESH:D056486 | Drug-Induced Liver Injury | Diethylnitrosamine | 11.80 | 19107877 | |
MESH:D056486 | Drug-Induced Liver Injury | Tetrachlorodibenzodioxin | 11.80 | 20420201 | |
MESH:D004362 | Drug Toxicity | Tetrachlorodibenzodioxin | 2.71 | 11462148 | |
MESH:D004421 | Dystonia | Phenobarbital | 3.94 | 1851702 | |
MESH:D004487 | Edema | Tetrachlorodibenzodioxin | 6.75 | 11000095 12711302 | |
MESH:D004487 | Edema | Tetradecanoylphorbol Acetate | 6.75 | 8273558 15177302 8113982 16716910 7812673 11698051 9599246 | |
MESH:D004489 | Edema, Cardiac | Tetrachlorodibenzodioxin | 3.85 | 15322242 18230668 16714409 | |
MESH:D004715 | Endometriosis | Tetrachlorodibenzodioxin | 2.96 | 10568697 9294722 | |
MESH:D004831 | Epilepsies, Myoclonic | Phenobarbital | 4.04 | 3659116 | |
MESH:D004828 | Epilepsies, Partial | Phenobarbital | 3.82 | 3922381 11558140 | |
MESH:D004827 | Epilepsy | Phenobarbital | 2.86 | 20417680 | |
MESH:D004832 | Epilepsy, Absence | Phenobarbital | 3.48 | 6401628 | |
MESH:D017029 | Epilepsy, Complex Partial | Phenobarbital | 4.19 | 7750514 | |
MESH:D004830 | Epilepsy, Tonic-Clonic | Phenobarbital | 3.96 | 3659116 | |
MESH:D004931 | Esophageal Achalasia | Diethylnitrosamine | 5.06 | 16302075 | |
MESH:D004938 | Esophageal Neoplasms | 4,4'-diaminodiphenylmethane | 7.20 | 3581430 | |
MESH:D004938 | Esophageal Neoplasms | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 7.20 | 20426865 | |
MESH:D004938 | Esophageal Neoplasms | Zinc | 7.20 | 16543248 | |
MESH:D005124 | Eye Abnormalities | Tetrachlorodibenzodioxin | 2.96 | 11564622 | |
MESH:D005234 | Fatty Liver | Cyclosporine | 7.51 | 19224547 | |
MESH:D005234 | Fatty Liver | Diethylnitrosamine | 7.51 | 21071580 20387270 | |
MESH:D005313 | Fetal Death | Tetrachlorodibenzodioxin | 3.39 | 11858732 | |
MESH:D005350 | Fibroma | 4,4'-diaminodiphenylmethane | 4.96 | 6705139 | |
MESH:D005355 | Fibrosis | Cyclosporine | 8.27 | 12168785 12639820 | |
MESH:D005355 | Fibrosis | Tetrachlorodibenzodioxin | 8.27 | 20067830 | |
MESH:D005706 | Gallbladder Neoplasms | S 1 (combination) | 5.70 | 19093184 | |
MESH:D005756 | Gastritis | Zinc | 4.74 | 17241300 | |
MESH:D030342 | Genetic Diseases, Inborn | vinclozolin | 4.87 | 16973722 | |
MESH:D005832 | Genital Diseases, Male | vinclozolin | 5.24 | 16417039 | |
MESH:D005885 | Gingival Hyperplasia | Cyclosporine | 4.16 | 8708960 | |
MESH:D006042 | Goiter | 4,4'-diaminodiphenylmethane | 3.97 | 7505956 | |
MESH:D006058 | Gonadal Disorders | Tetrachlorodibenzodioxin | 4.54 | 10696789 | |
MESH:D006130 | Growth Disorders | Zinc | 3.92 | 17217573 | |
MESH:D006258 | Head and Neck Neoplasms | S 1 (combination) | 4.70 | 15984520 18607998 | |
MESH:D006330 | Heart Defects, Congenital | 2,3,7,8-tetrachlorodibenzofuran | 6.86 | 11294989 | |
MESH:D006330 | Heart Defects, Congenital | Tetrachlorodibenzodioxin | 6.86 | 10048152 11294989 | |
MESH:D006333 | Heart Failure | Zinc | 3.57 | 17162251 | |
MESH:D006335 | Heart Injuries | Zinc | 5.71 | 17074742 | |
MESH:D016481 | Helicobacter Infections | Zinc | 4.47 | 17241300 | |
MESH:D006457 | Hemoglobinuria, Paroxysmal | Cyclosporine | 4.36 | 15720958 | |
MESH:D006470 | Hemorrhage | Tetrachlorodibenzodioxin | 3.27 | 11000095 | |
MESH:D006505 | Hepatitis | 4,4'-diaminodiphenylmethane | 3.45 | 6705139 | |
MESH:D006527 | Hepatolenticular Degeneration | Zinc | 4.63 | 17276780 | |
MESH:D006529 | Hepatomegaly | Phenobarbital | 8.23 | 16109766 | |
MESH:D006529 | Hepatomegaly | Tetrachlorodibenzodioxin | 8.23 | 16120746 15340226 12621046 | |
MESH:D019584 | Hot Flashes | venlafaxine | 5.48 | 14716179 | |
MESH:D006869 | Hydronephrosis | Tetrachlorodibenzodioxin | 3.99 | 18606429 8697196 16959395 16354765 15340226 | |
MESH:D006965 | Hyperplasia | 4,4'-diaminodiphenylmethane | 3.88 | 15034207 | |
MESH:D006973 | Hypertension | Cyclosporine | 4.86 | 10903974 | |
MESH:D006973 | Hypertension | Tetrachlorodibenzodioxin | 4.86 | 18670907 18850075 | |
MESH:D007248 | Infertility, Male | vinclozolin | 3.00 | 16467254 | |
MESH:D007249 | Inflammation | Diethylnitrosamine | 11.77 | 18785209 | |
MESH:D007249 | Inflammation | Flurbiprofen | 11.77 | 11099482 | |
MESH:D007249 | Inflammation | Tetrachlorodibenzodioxin | 11.77 | 12200463 12878042 | |
MESH:D007249 | Inflammation | Tetradecanoylphorbol Acetate | 11.77 | 15177302 8273558 11698051 7812673 7562506 | |
MESH:D007511 | Ischemia | Zinc | 4.57 | 16584753 | |
MESH:D007565 | Jaundice | 4,4'-diaminodiphenylmethane | 4.96 | 9022650 8074119 | |
MESH:D007569 | Jaw Abnormalities | Tetrachlorodibenzodioxin | 3.27 | 16580747 | |
MESH:D007638 | Keratoconjunctivitis Sicca | Cyclosporine | 4.39 | 15604871 | |
MESH:D007674 | Kidney Diseases | Cyclosporine | 6.08 | 8314463 10903974 18776723 | |
MESH:D007674 | Kidney Diseases | Zinc | 6.08 | 16960431 | |
MESH:D007676 | Kidney Failure, Chronic | Zinc | 4.36 | 16518626 | |
MESH:D007680 | Kidney Neoplasms | 2,4-dinitrotoluene | 17.28 | 16705839 | |
MESH:D007680 | Kidney Neoplasms | 2,6-dinitrotoluene | 17.28 | 16705839 | |
MESH:D007680 | Kidney Neoplasms | 4,4'-diaminodiphenylmethane | 17.28 | 6582329 | |
MESH:D007680 | Kidney Neoplasms | Cyclosporine | 17.28 | 12371664 | |
MESH:D007984 | Leydig Cell Tumor | vinclozolin | 4.67 | 16417039 | |
MESH:D008103 | Liver Cirrhosis | Diethylnitrosamine | 6.52 | 18665156 20032147 18522880 18407596 19638242 | |
MESH:D008103 | Liver Cirrhosis | Phenobarbital | 6.52 | 21047994 | |
MESH:D008105 | Liver Cirrhosis, Biliary | 4,4'-diaminodiphenylmethane | 3.15 | 9327722 15034207 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Tetrachlorodibenzodioxin | 1.24 | 12878042 | |
MESH:D008107 | Liver Diseases | Diethylnitrosamine | 4.05 | 17034775 | |
MESH:D008107 | Liver Diseases | Phenobarbital | 4.05 | 19363144 | |
MESH:D017114 | Liver Failure, Acute | venlafaxine | 5.34 | 19857765 | |
MESH:D008113 | Liver Neoplasms | 2,6-dinitrotoluene | 13.98 | 7678174 | |
MESH:D008113 | Liver Neoplasms | beta-Naphthoflavone | 13.98 | 21295105 19389873 | |
MESH:D008113 | Liver Neoplasms | Diethylnitrosamine | 13.98 | 19642983 20101389 18978307 21278145 16942905 19254457 20118626 19812893 19833225 12112319 9163691 19499222 2422723 19426721 20405173 20583210 15885732 15175105 19090486 19638242 10737359 19255062 19427195 19996281 20492335 18648771 2862719 19294768 19073162 20137499 19551842 12771043 21047994 20452335 19256749 18644402 20501860 18977376 21071580 18754104 20434301 19690152 19850985 21167192 | |
MESH:D008113 | Liver Neoplasms | Phenobarbital | 13.98 | 19812893 19073162 21047994 19482888 15975961 8742319 | |
MESH:D008113 | Liver Neoplasms | Tetrachlorodibenzodioxin | 13.98 | 16984957 | |
MESH:D008114 | Liver Neoplasms, Experimental | 2,6-dinitrotoluene | 22.84 | 2876784 6135515 2876786 | |
MESH:D008114 | Liver Neoplasms, Experimental | 4,4'-diaminodiphenylmethane | 22.84 | 6587162 1399818 598648 3712494 | |
MESH:D008114 | Liver Neoplasms, Experimental | beta-Naphthoflavone | 22.84 | 18164116 | |
MESH:D008114 | Liver Neoplasms, Experimental | Diethylnitrosamine | 22.84 | 19519916 18282651 18164116 16267830 18253720 18079962 3124819 18775883 19126423 18544905 21159647 19009564 17174075 19539802 18093689 17854601 19004024 18308698 9362446 16842330 17942915 2563599 | |
MESH:D008114 | Liver Neoplasms, Experimental | Phenobarbital | 22.84 | 1399818 17172636 6150874 2563599 18308698 | |
MESH:D008114 | Liver Neoplasms, Experimental | Tetrachlorodibenzodioxin | 22.84 | 12151625 | |
MESH:D008175 | Lung Neoplasms | Diethylnitrosamine | 3.43 | 21163286 20970405 20512841 6695378 | |
MESH:D008175 | Lung Neoplasms | Tetrachlorodibenzodioxin | 3.43 | 19555203 11884234 | |
MESH:D008175 | Lung Neoplasms | Tetradecanoylphorbol Acetate | 3.43 | 11807781 | |
MESH:D008325 | Mammary Neoplasms, Experimental | Tetradecanoylphorbol Acetate | 6.37 | 8985016 | |
MESH:D008325 | Mammary Neoplasms, Experimental | Zinc | 6.37 | 12773700 | |
MESH:D001523 | Mental Disorders | venlafaxine | 4.80 | 16856516 | |
MESH:D008664 | Metal Metabolism, Inborn Errors | Cyclosporine | 4.73 | 16801185 | |
MESH:D008881 | Migraine Disorders | venlafaxine | 4.72 | 18803445 | |
MESH:D017202 | Myocardial Ischemia | Tetrachlorodibenzodioxin | 2.96 | 12213967 | |
MESH:D020191 | Myoclonic Epilepsies, Progressive | Phenobarbital | 4.41 | 17484760 | |
MESH:D009336 | Necrosis | 2,4-dinitrotoluene | 10.14 | 18551238 | |
MESH:D009336 | Necrosis | 2,6-dinitrotoluene | 10.14 | 18551238 7678174 | |
MESH:D009362 | Neoplasm Metastasis | 4,4'-diaminodiphenylmethane | 5.61 | 3581430 | |
MESH:D009362 | Neoplasm Metastasis | Diethylnitrosamine | 5.61 | 3581430 9029167 | |
MESH:D009402 | Nephrosis, Lipoid | Cyclosporine | 4.39 | 17954296 | |
MESH:D009404 | Nephrotic Syndrome | Cyclosporine | 3.23 | 19348381 18481113 | |
MESH:D009421 | Nervous System Malformations | Tetrachlorodibenzodioxin | 3.15 | 14600291 | |
MESH:D009436 | Neural Tube Defects | 4,4'-diaminodiphenylmethane | 2.87 | 6679447 | |
MESH:D019636 | Neurodegenerative Diseases | Diethylnitrosamine | 3.28 | 20387270 | |
MESH:D009461 | Neurologic Manifestations | Diethylnitrosamine | 5.06 | 20387270 | |
MESH:D009771 | Obsessive-Compulsive Disorder | venlafaxine | 5.60 | 17503984 | |
MESH:D009784 | Occupational Diseases | 2,4-dinitrotoluene | 14.72 | 12819281 16049721 | |
MESH:D009784 | Occupational Diseases | 2,6-dinitrotoluene | 14.72 | 16049721 | |
MESH:D009784 | Occupational Diseases | 4,4'-diaminodiphenylmethane | 14.72 | 4026338 6482804 | |
MESH:D009902 | Optic Neuritis | 4,4'-diaminodiphenylmethane | 4.96 | 3988306 | |
MESH:D010018 | Osteomalacia | Phenobarbital | 4.30 | 17016548 | |
MESH:D010190 | Pancreatic Neoplasms | Diethylnitrosamine | 8.56 | 16540662 | |
MESH:D010190 | Pancreatic Neoplasms | Phenobarbital | 8.56 | 16965848 | |
MESH:D010190 | Pancreatic Neoplasms | Tetradecanoylphorbol Acetate | 8.56 | 15976015 | |
MESH:D010212 | Papilloma | 4,4'-diaminodiphenylmethane | 9.18 | 7296757 | |
MESH:D010212 | Papilloma | Tetradecanoylphorbol Acetate | 9.18 | 8330346 12065085 18404319 18922899 | |
MESH:D010382 | Peliosis Hepatis | Tetrachlorodibenzodioxin | 4.19 | 12520081 | |
MESH:D010787 | Photosensitivity Disorders | 4,4'-diaminodiphenylmethane | 4.41 | 6228378 | |
MESH:D017119 | Porphyria Cutanea Tarda | Tetrachlorodibenzodioxin | 3.49 | 18163543 | |
MESH:D011230 | Precancerous Conditions | Cyclosporine | 14.94 | 12371664 | |
MESH:D011230 | Precancerous Conditions | Diethylnitrosamine | 14.94 | 2563599 | |
MESH:D011230 | Precancerous Conditions | Phenobarbital | 14.94 | 2563599 | |
MESH:D011225 | Pre-Eclampsia | Zinc | 4.12 | 17114810 | |
MESH:D011297 | Prenatal Exposure Delayed Effects | Tetrachlorodibenzodioxin | 9.28 | 11222880 11896295 11399792 11118676 | |
MESH:D011297 | Prenatal Exposure Delayed Effects | vinclozolin | 9.28 | 19015723 18220299 18042343 | |
MESH:D011469 | Prostatic Diseases | vinclozolin | 4.87 | 18220299 | |
MESH:D011471 | Prostatic Neoplasms | Flurbiprofen | 3.99 | 17409433 | |
MESH:D011471 | Prostatic Neoplasms | Zinc | 3.99 | 16517595 12429649 16700911 16606632 | |
MESH:D011472 | Prostatitis | vinclozolin | 4.87 | 18629315 | |
MESH:D019310 | Pseudolymphoma | Phenobarbital | 4.44 | 12752131 | |
MESH:D011565 | Psoriasis | Cyclosporine | 2.21 | 16882103 | |
MESH:D015619 | Respiratory System Abnormalities | Tetrachlorodibenzodioxin | 3.77 | 18990726 | |
MESH:D012162 | Retinal Degeneration | 4,4'-diaminodiphenylmethane | 8.84 | 3692021 | |
MESH:D012162 | Retinal Degeneration | Zinc | 8.84 | 16584753 | |
MESH:D012640 | Seizures | 2,4-dinitrotoluene | 9.54 | 18551238 | |
MESH:D012640 | Seizures | 2,6-dinitrotoluene | 9.54 | 18551238 | |
MESH:D012640 | Seizures | Phenobarbital | 9.54 | 3137016 16876388 11442880 4039156 | |
MESH:D003294 | Seizures, Febrile | Phenobarbital | 4.76 | 6407741 | |
MESH:D012878 | Skin Neoplasms | Tetrachlorodibenzodioxin | 5.70 | 16192470 | |
MESH:D012878 | Skin Neoplasms | Tetradecanoylphorbol Acetate | 5.70 | 8330346 8985016 12065085 11807781 18404319 | |
MESH:D013274 | Stomach Neoplasms | Diethylnitrosamine | 2.98 | 18456281 | |
MESH:D013274 | Stomach Neoplasms | S 1 (combination) | 2.98 | 16557585 18506536 18553229 | |
MESH:D013959 | Thyroid Diseases | Tetrachlorodibenzodioxin | 3.85 | 12697716 | |
MESH:D013964 | Thyroid Neoplasms | 4,4'-diaminodiphenylmethane | 11.65 | 7505956 6582329 1399818 3712494 6587162 | |
MESH:D013964 | Thyroid Neoplasms | Diethylnitrosamine | 11.65 | 7505956 | |
MESH:D013964 | Thyroid Neoplasms | Phenobarbital | 11.65 | 1399818 | |
MESH:D014062 | Tongue Neoplasms | Zinc | 4.34 | 16543248 | |
MESH:D001749 | Urinary Bladder Neoplasms | 2,4-dinitrotoluene | 8.13 | 16049721 | |
MESH:D001749 | Urinary Bladder Neoplasms | 2,6-dinitrotoluene | 8.13 | 16049721 | |
MESH:D001749 | Urinary Bladder Neoplasms | 4,4'-diaminodiphenylmethane | 8.13 | 8074119 | |
MESH:D014571 | Urologic Neoplasms | 2,4-dinitrotoluene | 11.78 | 10091137 | |
MESH:D014571 | Urologic Neoplasms | 2,6-dinitrotoluene | 11.78 | 10091137 | |
MESH:D014605 | Uveitis | Cyclosporine | 3.93 | 1336536 | |
MESH:D054079 | Vascular Malformations | Tetrachlorodibenzodioxin | 4.54 | 12125929 | |
MESH:D019282 | Wasting Syndrome | Tetrachlorodibenzodioxin | 4.19 | 15886252 | |
MESH:D014985 | Xerophthalmia | Cyclosporine | 4.39 | 17120751 |
Pathway ID | Pathway Name |
---|---|
KEGG:04520 | Adherens junction |